Femoro-popliteal Endovascular Interventions

Overview

Journal Wideochir Inne Tech Maloinwazyjne

Publisher Termedia

Date 2024 Jul 8

PMID 38973798

Authors

Azat Chinaliyev

Samat Saparbayev

Bazylbek Zhakiyev

Gulinur Chinaliyeva

Didar Khassenov

Irlan Sagandykov

Ibrahim A Abdelazim

Ainur Donayeva

Ainur Amanzholkyzy

Batyrbek Alibekov

Luis Arias

Nazgul Dzhantemirova

Zhenisbek Baubekov

Bibigul Karimsakova

Affiliations

Soon will be listed here.

Abstract

Peripheral artery disease (PAD) is a worldwide major health challenge, and it is a strong predictor of mortality and morbidity. The advances in PAD treatment have resulted in many therapeutic options or endovascular interventions (EVIs) for endovascular revascularization if drug therapy does not lead to substantial improvement. Randomized controlled trials (RCTs) have reported the efficacy of various EVIs such as atherectomy, stents, and medicated balloons over the traditional transluminal angioplasty; however, the standard treatment for PAD remains unclear due to the lack of head-to-head comparative studies between different EVIs. Additionally, the variable outcomes between clinical trials regarding the functional capacity and quality of life (QoL) make it difficult to ascertain the superiority of one particular EVI over another. Therefore, the latest PAD clinical trials should include head-to-head comparisons between different EVIs, and this review aimed to highlight the femoro-popliteal EVIs, evidence supporting each intervention and why those EVIs are used.

References

Dake M, Ansel G, Jaff M, Ohki T, Saxon R, Smouse H . Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation. 2016; 133(15):1472-83. PMC: 4823823. DOI: 10.1161/CIRCULATIONAHA.115.016900. View

Dattilo R, Himmelstein S, Cuff R . The COMPLIANCE 360° Trial: a randomized, prospective, multicenter, pilot study comparing acute and long-term results of orbital atherectomy to balloon angioplasty for calcified femoropopliteal disease. J Invasive Cardiol. 2014; 26(8):355-60. View

Scheinert D, Duda S, Zeller T, Krankenberg H, Ricke J, Bosiers M . The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty. JACC Cardiovasc Interv. 2014; 7(1):10-9. DOI: 10.1016/j.jcin.2013.05.022. View

Hirsch A, Haskal Z, Hertzer N, Bakal C, Creager M, Halperin J . ACC/AHA Guidelines for the Management of Patients with Peripheral Arterial Disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Associations for Vascular Surgery/Society for Vascular Surgery,.... J Vasc Interv Radiol. 2006; 17(9):1383-97. DOI: 10.1097/01.RVI.0000240426.53079.46. View

Marzlin N, Jan M, Kostopoulos L, Perez Moreno A, Bajwa T, Allaqaband S . Peripheral Artery Disease Intervention: Drug-Coated Balloon vs Drug-Eluting Stent, A Long-Term Comparison. J Interv Cardiol. 2022; 2022:5175607. PMC: 9440843. DOI: 10.1155/2022/5175607. View

Barton M, Gruntzig J, Husmann M, Rosch J . Balloon Angioplasty - The Legacy of Andreas Grüntzig, M.D. (1939-1985). Front Cardiovasc Med. 2015; 1:15. PMC: 4671350. DOI: 10.3389/fcvm.2014.00015. View

Jia X, Zhang J, Zhuang B, Fu W, Wu D, Wang F . Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence From the AcoArt I Trial. JACC Cardiovasc Interv. 2016; 9(18):1941-9. DOI: 10.1016/j.jcin.2016.06.055. View

Natarajan B, Patel P, Mukherjee A . Acute Lower Limb Ischemia-Etiology, Pathology, and Management. Int J Angiol. 2020; 29(3):168-174. PMC: 7577793. DOI: 10.1055/s-0040-1713769. View

Schillinger M, Minar E . Claudication: treatment options for femoropopliteal disease. Prog Cardiovasc Dis. 2011; 54(1):41-6. DOI: 10.1016/j.pcad.2011.04.003. View

10.

Geraghty P, Mewissen M, Jaff M, Ansel G . Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg. 2013; 58(2):386-95.e4. DOI: 10.1016/j.jvs.2013.01.050. View

11.

Jaff M, Nelson T, Ferko N, Martinson M, Anderson L, Hollmann S . Endovascular Interventions for Femoropopliteal Peripheral Artery Disease: A Network Meta-Analysis of Current Technologies. J Vasc Interv Radiol. 2017; 28(12):1617-1627.e1. DOI: 10.1016/j.jvir.2017.08.003. View

12.

Criqui M, Denenberg J, Bird C, Fronek A, Klauber M, Langer R . The correlation between symptoms and non-invasive test results in patients referred for peripheral arterial disease testing. Vasc Med. 1996; 1(1):65-71. DOI: 10.1177/1358863X9600100112. View

13.

Herten M, Stahlhoff S, Imm B, Schonefeld E, Schwindt A, Torsello G . [Drug-coated balloons in the treatment of peripheral artery disease (PAD). History and current level of evidence]. Radiologe. 2016; 56(3):240-53. DOI: 10.1007/s00117-015-0073-7. View

14.

Meijers T, Aminian A, van Wely M, Teeuwen K, Schmitz T, Dirksen M . Randomized Comparison Between Radial and Femoral Large-Bore Access for Complex Percutaneous Coronary Intervention. JACC Cardiovasc Interv. 2021; 14(12):1293-1303. DOI: 10.1016/j.jcin.2021.03.041. View

15.

Jongsma H, van Mierlo-van den Broek P, Imani F, van den Heuvel D, de Vries J, Fioole B . Randomized comparison of femoropopliteal artery drug-eluting balloons and drug-eluting stents (FOREST trial): Study protocol for a randomized controlled trial. J Vasc Surg. 2017; 66(4):1293-1298. DOI: 10.1016/j.jvs.2017.05.098. View

16.

Latacz P, Simka M, Brzegowy P, Piwowarczyk M, Popiela T . Mechanical rotational thrombectomy with Rotarex system augmented with drug-eluting balloon angioplasty versus stenting for the treatment of acute thrombotic and critical limb ischaemia in the femoropopliteal segment. Wideochir Inne Tech Maloinwazyjne. 2019; 14(2):311-319. PMC: 6528111. DOI: 10.5114/wiitm.2018.80006. View

17.

Jongsma H, Bekken J, Ayez N, Hoogewerf C, van Weel V, Fioole B . Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev. 2020; 12:CD007561. PMC: 8092482. DOI: 10.1002/14651858.CD007561.pub3. View

18.

Diamantopoulos A, Katsanos K . Treating femoropopliteal disease: established and emerging technologies. Semin Intervent Radiol. 2014; 31(4):345-52. PMC: 4232427. DOI: 10.1055/s-0034-1393971. View

19.

Krishnan P, Faries P, Niazi K, Jain A, Sachar R, Bachinsky W . Stellarex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes From the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies. Circulation. 2017; 136(12):1102-1113. PMC: 5598919. DOI: 10.1161/CIRCULATIONAHA.117.028893. View

20.

Werk M, Albrecht T, Meyer D, Ahmed M, Behne A, Dietz U . Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv. 2012; 5(6):831-40. DOI: 10.1161/CIRCINTERVENTIONS.112.971630. View